AI Verdict
SAMG has stronger fundamentals based on our AI analysis.
SANA vs SAMG Fundamental Comparison
| Metric | SANA | SAMG |
|---|---|---|
| Revenue | N/A | $125.3M |
| Net Income | $-244.2M | $4.9M |
| Net Margin | N/A | 3.9% |
| ROE | -151.8% | 9.7% |
| ROA | -58.6% | 2.9% |
| Current Ratio | 1.89x | N/A |
| Debt/Equity | 0.00x | 0.01x |
| EPS | $-0.96 | $0.56 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
SANA vs SAMG: Frequently Asked Questions
Is SANA or SAMG a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), SAMG has stronger fundamentals. SANA is rated SELL (72% confidence) while SAMG is rated HOLD (78% confidence). This is not investment advice.
How does SANA compare to SAMG fundamentally?
Sana Biotechnology, Inc. has ROE of -151.8% vs Silvercrest Asset Management Group Inc.'s 9.7%. Net margins are N/A vs 3.9% respectively.
Which stock pays higher dividends, SANA or SAMG?
SANA has a dividend yield of N/A or no dividend while SAMG has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in SANA or SAMG for long term?
For long-term investing, consider that SANA has SELL rating with 72% confidence, while SAMG has HOLD rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about SANA vs SAMG?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For SANA vs SAMG, the AI consensus favors SAMG based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.